Biolab link set to build Nichi-Iko's Thai generic sales
This article was originally published in Scrip
Executive Summary
Nichi-Iko Pharmaceutical, one of Japan's largest generics companies, has entered into an alliance with the Thai contract manufacturing group Biolab as part of its strategic Asian expansion plan.